相关实验视频

Updated: Jul 26, 2025

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

肯尼亚卡吉亚多肺里芬辛耐药结核病的负担:一项观察性研究

Paolo Cattaneo¹, Caleb Mike Mulongo², Gianfranco Morino³

¹Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.

|June 15, 2023

概括

肯尼亚卡吉阿多县的抗利芬素结核病 (RR-TB) 患病率是官方报告的四倍. 该研究强调,迫切需要加强该地区的结核病诊断能力.

科学领域:

公共卫生公共卫生
传染性疾病传染性疾病
流行病学流行病学

背景情况:

里芬素耐药性 (RR) 在结核病 (TB) 管理中构成了重大挑战.
在许多地区,关于RR-TB患病率的数据仍然有限,需要进行本地估计.
由于对RR-TB的数据稀少,肯尼亚的Kajiado县被选为这项研究.

研究的目的:

估计肯尼亚卡吉阿多县RR-TB的流行率.
为了确定研究区域内的成年人肺结核发病率.
评估肺结核诊断患者中艾滋病毒-结核同时感染的比率.

主要方法:

作为ATI-TB项目的一部分,在Kajiado县进行了一项观察性研究.
积极的案例寻找利用了社区卫生志愿者,村长和传统治疗师.
使用Xpert MTB/RIF进行诊断,包括用于偏远地区的移动单元.

主要成果:

总共有3840名成年人接受了活跃结核病查.
在所有结核病诊断中,RR-TB的患病率为4.6%.
成年人肺结核的年发病率为每10万人口中有521人,艾滋病毒同时感染率为22.2%.

结论:

卡吉亚多的RR-TB患病率是官方估计的四倍,超过肯尼亚的总体患病率.
成年人肺结核发病率估计与已报告的病例有显著差异.
艾滋病毒共感染率与国家和地区数据保持一致,但Kajiado的诊断能力需要加强.

关键词:

艾滋病毒感染并发的同时感染.卡吉阿多 (Kajiado) 是一个国家.肯尼亚肯尼亚肯尼亚肯尼亚积极病例的发现.里芬辛的耐药性里芬辛的耐药性结核病是一种肺结核病.

更多相关视频

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.